Osaka, Japan

Kazuhiro Okochi



Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kazuhiro Okochi: Innovator in Pharmaceutical Formulations

Introduction

Kazuhiro Okochi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 3 patents to his name, Okochi's work has had a meaningful impact on the industry.

Latest Patents

Okochi's latest patents include a pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative. This invention describes a pharmaceutical dosage form that comprises a controlled release component featuring an antihyperglycemic drug in combination with a second component that includes a thiazolidinedione derivative. Another significant patent is an oral preparation comprising pioglitazone. This invention provides an oral preparation that effectively masks the bitter taste of pioglitazone and its salts, utilizing alkali metal chloride to enhance the formulation.

Career Highlights

Throughout his career, Kazuhiro Okochi has worked with prominent companies in the pharmaceutical sector. He has been associated with Takeda Pharmaceutical Company Limited and Actavis, Inc., where he contributed to various innovative projects and advancements in drug formulations.

Collaborations

Okochi has collaborated with several talented individuals in his field, including Arisa Maeda and Unchalee Lodin. These collaborations have further enriched his work and contributed to the success of his inventions.

Conclusion

Kazuhiro Okochi stands out as an influential inventor in the pharmaceutical industry, with a focus on creating effective drug formulations. His contributions continue to shape the landscape of pharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…